Cambridge Theranostics
A New Treatment For Atherosclerosis
products                                                                                              

Ateronon®/TM

A new cardiovascular product (once daily tablet) to be launched 2008.
Ateronon
 >more information

AtheroAbzyme®/TM IgG ELISA

To determine the level of lipid-oxidising antibodies.
AtheroAbzyme IgG ELISA
 >more information

Research Reagents
Research Reagents

>more information

 
 
 
 
about us | products | disease mechanism | publications | media | management | contact us

© Copyright Cambridge Theranostics 2008. Registered in England and Wales No: 4314866; Registered office: 7 Hills Avenue, Cambridge CB1 7UY

class="bodyText">Cambridge Theranostics Ltd .